Abbvie Inc
NYSE: ABBV
$181.14
+$4.08 (+2.3%)
Closing Price on November 26, 2024
ABBV Articles
AbbVie reported better-than-expected second-quarter financial results before the markets opened on Friday.
Published:
Last Updated:
The July 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the report's top picks: AbbVie, Eli Lilly, Merck, and Shire.
Published:
Last Updated:
The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could have the biggest boom or bust at the conference.
Published:
Last Updated:
The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be...
Published:
Last Updated:
A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow they have for the rest of 2017.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly upward.
Published:
Last Updated:
AbbVie watched its shares slide on Wednesday following a ruling from the U.S. Patent and Trade Mark Office's Trial and Appeals Board that found in favor of Coherus Biosciences.
Published:
Last Updated:
Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.
Published:
Last Updated:
The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward.
Published:
Last Updated:
The analysts at Jefferies have made a big move by adding a top consumer goods/auto parts company to the firm's well-respected Franchise Picks list of stocks to buy.
Published:
Last Updated:
24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their earnings on Thursday.
Published:
Last Updated: